Insider Transactions in Q1 2023 at Idera Pharmaceuticals, Inc. (IDRA)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2023
|
John Clayton Taylor CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,341,764
+47.73%
|
-
|
|
Jan 17
2023
|
Daniel Salain CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,341,764
+47.73%
|
-
|
|
Jan 17
2023
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
402,529
+47.11%
|
-
|
|
Jan 11
2023
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
33,523
+8.2%
|
$0
$0.44 P/Share
|
|
Jan 06
2023
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
119,957
-27.46%
|
$0
$0.71 P/Share
|
|
Jan 06
2023
|
John J. Kirby CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
399,218
+47.75%
|
-
|
|
Jan 06
2023
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
119,957
-27.92%
|
$0
$0.71 P/Share
|
|
Jan 06
2023
|
Bryant David Lim SVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
399,218
+48.16%
|
-
|
|
Jan 06
2023
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
73,940
-8.1%
|
$0
$0.71 P/Share
|
|
Jan 06
2023
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
261,718
+22.28%
|
-
|